China NT Pharma Group Company Limited (HKG:1011)
Hong Kong
· Delayed Price · Currency is HKD 0.670
+0.020 (3.08%)
Apr 29, 2026, 3:38 PM HKT
HKG:1011 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | - | -53.36 | -143.59 | -66.41 | -149.54 | Upgrade
|
| Depreciation & Amortization | - | 0.66 | 5.55 | 20.65 | 41.82 | Upgrade
|
| Other Amortization | - | - | 0.33 | 5.53 | 0.43 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 7.01 | -12.29 | - | -41.04 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 0.12 | 0.01 | 0.08 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | 5.92 | - | 0.63 | 6.04 | Upgrade
|
| Loss (Gain) on Equity Investments | - | -10.24 | -37.04 | -9 | -34.49 | Upgrade
|
| Stock-Based Compensation | - | - | - | 0.6 | 0.08 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | 1.66 | 0.25 | 9.74 | Upgrade
|
| Other Operating Activities | - | 37.68 | 160.82 | 100.33 | 124.23 | Upgrade
|
| Change in Accounts Receivable | - | -1 | 67.33 | -32.11 | 7.94 | Upgrade
|
| Change in Inventory | - | -0.17 | -2.53 | 19.88 | -5.19 | Upgrade
|
| Change in Accounts Payable | - | 4.31 | 16.72 | -1.03 | -94.81 | Upgrade
|
| Change in Other Net Operating Assets | - | - | - | 1.06 | -0.56 | Upgrade
|
| Operating Cash Flow | - | -9.07 | 50.48 | 36.21 | -135.34 | Upgrade
|
| Operating Cash Flow Growth | - | - | 39.40% | - | - | Upgrade
|
| Capital Expenditures | - | -0.18 | -10.73 | -4.49 | -0.65 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0.16 | - | 32.56 | Upgrade
|
| Cash Acquisitions | - | - | - | - | -4.97 | Upgrade
|
| Divestitures | - | -0.02 | -0.2 | - | 438.71 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | -2.16 | - | - | Upgrade
|
| Investment in Securities | - | - | - | 9 | -232.59 | Upgrade
|
| Other Investing Activities | - | 0.01 | -9.21 | 0.02 | 24.76 | Upgrade
|
| Investing Cash Flow | - | -0.19 | -22.14 | 4.53 | 257.81 | Upgrade
|
| Long-Term Debt Issued | - | 30.67 | 18.08 | 53.38 | 83.22 | Upgrade
|
| Total Debt Issued | - | 30.67 | 18.08 | 53.38 | 83.22 | Upgrade
|
| Long-Term Debt Repaid | - | -8.03 | -37.2 | -82.38 | -164.69 | Upgrade
|
| Total Debt Repaid | - | -8.03 | -37.2 | -82.38 | -164.69 | Upgrade
|
| Net Debt Issued (Repaid) | - | 22.64 | -19.12 | -29 | -81.47 | Upgrade
|
| Issuance of Common Stock | - | - | 9.39 | 2.02 | - | Upgrade
|
| Other Financing Activities | - | -9.99 | -19.24 | -19.7 | -43.33 | Upgrade
|
| Financing Cash Flow | - | 12.65 | -28.97 | -46.68 | -124.8 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 4.71 | 0.24 | 3.49 | 3.37 | Upgrade
|
| Net Cash Flow | - | 8.1 | -0.4 | -2.45 | 1.05 | Upgrade
|
| Free Cash Flow | - | -9.24 | 39.74 | 31.72 | -135.98 | Upgrade
|
| Free Cash Flow Growth | - | - | 25.31% | - | - | Upgrade
|
| Free Cash Flow Margin | - | -24.35% | 539.55% | - | -59.98% | Upgrade
|
| Free Cash Flow Per Share | - | -0.04 | 0.17 | 0.17 | -0.72 | Upgrade
|
| Cash Interest Paid | - | 9.99 | 18.77 | 17.57 | 42.86 | Upgrade
|
| Cash Income Tax Paid | - | - | 0.86 | 1.04 | 0.8 | Upgrade
|
| Levered Free Cash Flow | - | 10.18 | 14.34 | 238.01 | 159.33 | Upgrade
|
| Unlevered Free Cash Flow | - | 29.89 | 32.36 | 262.61 | 214.78 | Upgrade
|
| Change in Working Capital | - | 3.15 | 81.52 | -12.19 | -92.62 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.